Penile reinnervation as a new technique for treating erectile dysfunction in patients after radical prostatectomy

Nowadays, radical prostatectomy (RPE) is the «gold standard» in the treatment of localized prostate cancer (PCa). However, this intervention is associated with a high risk of developing iatrogenic erectile dysfunction (ED), which significantly reduces the quality of life of a man. One of the surgical solutions to this complication is the installation of a penile prosthesis. Nevertheless, it must be borne in mind that this manipulation is associated with certain risks of intra-and postoperative complications. During the operation, there may be complications such as perforation (cavernous, septal, urethral), crossover (intersection of rods or cylinders), haemorrhage, difficulties in suturing the operating wound, damage to the components of the prosthesis. The most common problem is an infection in the postoperative period. It is also worth noting the high cost of implants and artificial erection, which is crucial for some young patients. Countries around the world are searching for new methods to restore physiological erectile function in patients after RPE. Recently, the attention of specialists has been drawn to the possibility of restoring the innervation of the penis by transplanting a nerve graft. The study aimed to provide a general idea of the ED treatment in patients after RPE by nerve graft transplantation with the development and realization of our own described at the end as a clinical case.

1. van Poppel H, Everaerts W, Tosco L, Joniau S. Open and robotic radical prostatectomy. Asian J urol. 2019;6(2):125-128. https://doi.org/10.1016/j.ajur.2018.12.002

2. Schostak M, Miller K, Schrader M. Radical prostatectomy in the 21st century - the gold standard for localized and locally advanced prostate cancer. Front Radiat Ther Oncol. 2008;41:7-14. https://doi.org/10.1159/000139873

3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492

4. Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, LamTB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouviere O, Schoots IG, Wiegel T, Cornford P. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2017;71(4):618-629. https://doi.org/10.1016/j.eururo.2016.08.003

5. Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Sama-ratunga H, Zajdlewicz L, Teloken P, Dunglison N, Williams S, Lavin MF, Gardiner RA. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol. 2018;19(8):1051-1060. https://doi.org/10.1016/S1470-2045(18)30357-7

6. Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years. JAMA. 2017;317(11):1126-1140. https://doi.org/10.1001/jama.2017.1704. Erratum in: JAMA. 2017;317(20):2134.

7. Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med. 1998;13(3):159-66. https://doi.org/10.1046/j.1525-1497.1998.00050.x

8. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250-61. https://doi.org/10.1056/NEJMoa074311

9. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993;270(1):83-90. PMID: 8510302

10. Fode M, 0stergren PB, Jensen CFS, Jakobsen H, S0nksen J. Treatment effects of phosphodiesterase-5 inhibitors may improve with time following nerve-sparing radical prostatectomy. Scand J Urol. 2018;52(2):108-110. https://doi.org/10.1080/21681805.2017.1387603

11. Andersson KE. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev. 2011;63(4):811-59. https://doi.org/10.1124/pr.111.004515

12. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 1982;128(3):492-7. https://doi.org/10.1016/s0022-5347(17)53012-8

13. Popov S.V., Orlov I.N., Grin' Y.A., Malevich S.M., Gul'ko A.M., Topuzo T.M., Kyzlasov P.S., Povelitsa E.A. Erectile dysfunction: new technologies and approaches in diagnostics and treatment. Urology Herald. 2020;8(2):78-92. (In Russ.) https://doi.org/10.21886/2308-6424-2020-8-2-78-92

14. Jung J, Jo HW, Kwon H, Jeong NY. Clinical neuroanatomy and neurotransmitter-mediated regulation of penile erection. Int Neurourol J. 2014;18(2):58-62. https://doi.org/10.5213/inj.2014.18.2.58

15. Burnett AL, Tillman SL, Chang TS, Epstein JI, Lowenstein CJ, Bredt DS, Snyder SH, Walsh PC. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J Urol. 1993;150(1):73-6. https://doi.org/10.1016/S0022-5347(17)35401-0

16. Hedlund P, Ny L, Alm P, Andersson KE. Cholinergic nerves in human corpus cavernosum and spongiosum contain nitric oxide synthase and heme oxygenase. J Urol. 2000;164(3 Pt 1):868-75. https://doi.org/10.1016/S0022-5347(05)67329-6

17. Dail WG, Barba V, Leyba L, Galindo R. Neural and endothelial nitric oxide synthase activity in rat penile erectile tissue. Cell Tissue Res. 1995;282(1):109-16. https://doi.org/10.1007/BF00319137

18. Domoto T, Tsumori T. Co-localization of nitric oxide synthase and vasoactive intestinal peptide immunoreactivity in neurons of the major pelvic ganglion projecting to the ratrectum and penis. Cell Tissue Res. 1994;278(2):273-8. https://doi.org/10.1007/BF00414170

19. Saenz de Tejada I, Blanco R, Goldstein I, Azadzoi K, de las Morenas A, Krane RJ, Cohen RA. Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue. Am J Physiol. 1988;254(3 Pt 2):H459-67. https://doi.org/10.1152/ajpheart.1988.254.3.H459

20. McConnell J, Benson GS. Innervation of human penile blood vessels. Neurourol Urodyn. 1982;1:199-210 https://doi.org/10.1002/nau.1930010213

21. Quinlan DM, Nelson RJ, Walsh PC. Cavernous nerve grafts restore erectile function in denervated rats. J Urol. 1991;145(2):380-3. https://doi.org/10.1016/s0022-5347(17)38348-9

22. Ball RA, Lipton SA, Dreyer EB, Richie JP, Vickers MA. Entubu-lization repair of severed cavernous nerves in the rat resulting in return of erectile function. J. Urol. 1992;148(1):211-5. https://doi.org/10.1016/S0022-5347(17)36555-2

23. Ballance CA, Ballance HA, Stewart P. Remarks on the operative treatment of chronic facial palsy of peripheral origin. Br Med J. 1903;1(2209):1009-13. https://doi.org/10.1136/bmj.1.2209.1009

24. Viterbo F, Teixeira E, Hoshino K, Padovani CR. End-to-side neurorrhaphy with and without perineurium. Sao Paulo Med J. 1998;116(5):1808-14. https://doi.org/10.1590/s1516-31801998000500005

25. Viterbo F, Trindade JC, Hoshino K, Mazzoni A. Two end-to-side neurorrhaphies and nerve graft with removal of the epineural sheath: experimental study in rats. Br J Plast Surg. 1994;47(2):75-80. https://doi.org/10.1016/0007-1226(94)90162-7

26. Viterbo F, Trindade JC, Hoshino K, Mazzoni Neto A. Latero-terminal neurorrhaphy without removal of the epineural sheath. Experimental study in rats. Rev Paul Med. 1992;110(6):267-75. Erratum in: Rev Paul Med. 1993;111(6):479. PMID: 1341024

27. Matsuda K, Kakibuchi M, Kubo T, Tomita K, Fujiwara T, Hattori R, Yano K, Hosokawa K. A new model of end-to-side nerve graft for multiple branch reconstruction: end-to-side cross-face nerve graft in rats. J Plast Reconstr Aesthet Surg. 2008;61(11):1357-67. https://doi.org/10.1016/j.bjps.2008.04.013

28. Okochi M, Ueda K, Okochi H, Asai E, Sakaba T, Kajikawa A. Facial reanimation using hypoglossal-facial neurorrhaphy with end-to-side coaptation between the jump interpositional nerve graft and hypoglossal nerve: Outcome and duration of preoperative paralysis. Microsurgery. 2016;36(6):460-6. https://doi.org/10.1002/micr.22393

29. Viterbo F, Romao A, Brock RS, Joethy J. Facial reanimation utilizing combined orthodromic temporalis muscle flap and end-to-side cross-face nerve grafts. Aesthetic Plast Surg. 2014;38(4):788-95. https://doi.org/10.1007/s00266-014-0357-8

30. Rovak JM, Cederna PS, Macionis V, Urbanchek MS, Van Der Meulen JH, Kuzon WM Jr. Termino-lateral neurorrhaphy: the functional axonal anatomy. Microsurgery. 2000;20(1):6-14. https://doi.org/10.1002/(sici)1098-2752(2000)20:1<6::aid-micr2>3.0.co;2-5

31. Hosseinian MA, Gharibi Loron A, Nemati B, Khandaghy M. Comparison of a distal end-to-side neurorrhaphy with a proximal-distal end-to-side neurorrhaphy: in a rat model. Eur J Orthop Surg Traumatol. 2015;25(8):1261-4. https://doi.org/10.1007/s00590-015-1699-x

32. Kim ED, Scardino PT, Hampel O, Mills NL, Wheeler TM, Nath RK. Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy. J Urol. 1999;161(1):188-92. PMID: 10037395

33. Kim ED, Nath R, Slawin KM, Kadmon D, Miles BJ, Scardino PT. Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up. Urology. 2001;58(6):983-7. https://doi.org/10.1016/s0090-4295(01)01403-0

34. Secin FP, Koppie TM, Scardino PT, Eastham JA, Patel M, Bianco FJ, Tal R, Mulhall J, Disa JJ, Cordeiro PG, Rabbani F. Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience. J Urol. 2007;177(2):664-8. https://doi.org/10.1016/j.juro.2006.09.035

35. Namiki S, Saito S, Nakagawa H, Sanada T, Yamada A, Arai Y. Impact of unilateral sural nerve graft on recovery of potency and continence following radical prostatectomy: 3-year longitudinal study. J Urol. 2007;178(1):212-6; discussion 216. https://doi.org/10.1016/j.juro.2007.03.043

36. Nelson BA, Chang SS, Cookson MS, Smith JA Jr. Morbidity and efficacy of genitofemoral nerve grafts with radical retropubic prostatectomy. Urology. 2006;67(4):789-92. https://doi.org/10.1016/j.urology.2005.10.004

37. Porpiglia F, Ragni F, Terrone C, Renard J, Musso F, Grande S, Cracco C, Ghignone G, Scarpa RM. Is laparoscopic unilateral sural nerve grafting during radical prostatectomy effective in retaining sexual potency? BJU Int. 2005;95(9):1267-71. https://doi.org/10.1111/j.1464-410X.2005.05501.x

38. Davis JW, Chang DW, Chevray P, Wang R, Shen Y, Wen S, Pettaway CA, Pisters LL, Swanson DA, Madsen LT, Huber N, Troncoso P, Babaian RJ, Wood CG. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer. Eur Urol. 2009;55(5):1135-43. https://doi.org/10.1016/j.eururo.2008.08.051

39. Dong C, Dong Z, Xie Z, Zhang L, Xiong F, Wen Q, Fan Z, Peng Q. Functional Restoration of Erectile Function Using End-to-side Autonomic-to-somatic Neurorrhaphy in Rats. Urology. 2016;95:108-14. https://doi.org/10.1016/j.urology.2016.05.017

40. Souza Trindade JC, Viterbo F, Petean Trindade A, Favaro WJ, Trindade-Filho JCS. Long-term follow-up of treatment of erectile dysfunction after radical prostatectomy using nerve grafts and end-to-side somatic-autonomic neurorraphy: a new technique. BJU Int. 2017;119(6):948-954. https://doi.org/10.1111/bju.13772

41. Haninec P, Kaiser R, Dubovy P. A comparison of collateral sprouting of sensory and motor axons after end-to-side neurorrhaphy with and without the perineurial window. Plast Reconstr Surg. 2012;130(3):609-14. https://doi.org/10.1097/PRS.0b013e31825dc20a

42. Scaglione F, Donde S, Hassan TA, Jannini EA. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction: pharmacology and clinical impact of the sildenafil citrate orodispersible tablet formulation. Clin Ther. 2017;39(2):370-377. https://doi.org/10.1016/j.clinthera.2017.01.001